Literature DB >> 21235674

Prevalence and predictors of complications of radiofrequency catheter ablation for atrial fibrillation.

Timir S Baman1, Krit Jongnarangsin, Aman Chugh, Arisara Suwanagool, Aurelie Guiot, Arin Madenci, Spencer Walsh, Karl J Ilg, Sanjaya K Gupta, Rakesh Latchamsetty, Suveer Bagwe, James D Myles, Thomas Crawford, Eric Good, Frank Bogun, Frank Pelosi, Fred Morady, Hakan Oral.   

Abstract

INTRODUCTION: Up to 6% of patients experience complications after radiofrequency catheter ablation (RFA) of atrial fibrillation (AF). The purpose of this study is to determine the prevalence and predictors of periprocedural complications after RFA for AF. METHODS AND
RESULTS: The subjects were 1,295 consecutive patients (age = 60 ± 10 years) who underwent RFA (n = 1,642) for paroxysmal (53%) or persistent AF (47%) from January 2007 to January 2010. A complication occurred in 57 patients (3.5%); a vascular access complication in 31 (1.9%); pericardial tamponade in 20 (1.2%); a thromboembolic event in 4 (0.2%); deep venous thrombosis in 1 (<0.01%); and pulmonary vein stenosis in 1 patient (<0.01%). There were no procedure-related deaths. On multivariate analysis, female gender (OR = 2.27; ±95% CI: 1.31-2.57, P < 0.01) and procedures performed in July or August (OR = 2.10; ±95% CI: 1.16-3.80, P = 0.01) were independent predictors of any complication. For vascular complications, treatment with clopidogrel (OR = 4.40; ±95% CI: 1.43-13.53, P = 0.01), female gender (OR = 3.65; ±95% CI: 1.72-7.75, P < 0.01) and performing RFA in July or August (OR = 2.71; ±95% CI: 1.25-5.87, P = 0.01) were independent predictors. The only predictor of cardiac tamponade was prior RFA (OR = 3.32; ±95% CI: 0.95-11.61; P < 0.05).
CONCLUSION: Prevalence of perioperative complications for RFA of AF is 3.5% and vascular access complications constitute the majority. The need for clopidogrel therapy should be carefully considered prior to RFA. At teaching institutions close supervision should be exercised during vascular access early in the year. Improvements in ablation technology and elimination of the need for repeat procedures may decrease the risk of pericardial tamponade.
© 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21235674      PMCID: PMC3471534          DOI: 10.1111/j.1540-8167.2010.01995.x

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  18 in total

1.  Movement of the esophagus during left atrial catheter ablation for atrial fibrillation.

Authors:  Eric Good; Hakan Oral; Kristina Lemola; Jihn Han; Kamala Tamirisa; Petar Igic; Darryl Elmouchi; David Tschopp; Scott Reich; Aman Chugh; Frank Bogun; Frank Pelosi; Fred Morady
Journal:  J Am Coll Cardiol       Date:  2005-11-09       Impact factor: 24.094

2.  Variation in left atrial transmural wall thickness at sites commonly targeted for ablation of atrial fibrillation.

Authors:  Burr Hall; Vinodh Jeevanantham; Rochelle Simon; John Filippone; Gabriel Vorobiof; James Daubert
Journal:  J Interv Card Electrophysiol       Date:  2007-01-17       Impact factor: 1.900

3.  Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation.

Authors:  Riccardo Cappato; Hugh Calkins; Shih-Ann Chen; Wyn Davies; Yoshito Iesaka; Jonathan Kalman; You-Ho Kim; George Klein; Douglas Packer; Allan Skanes
Journal:  Circulation       Date:  2005-02-21       Impact factor: 29.690

4.  Common femoral artery anatomy is influenced by demographics and comorbidity: implications for cardiac and peripheral invasive studies.

Authors:  G Schnyder; N Sawhney; B Whisenant; S Tsimikas; Z G Turi
Journal:  Catheter Cardiovasc Interv       Date:  2001-07       Impact factor: 2.692

5.  A July spike in fatal medication errors: a possible effect of new medical residents.

Authors:  David P Phillips; Gwendolyn E C Barker
Journal:  J Gen Intern Med       Date:  2010-05-29       Impact factor: 5.128

6.  Detection of pulmonary vein and left atrial scar after catheter ablation with three-dimensional navigator-gated delayed enhancement MR imaging: initial experience.

Authors:  Dana C Peters; John V Wylie; Thomas H Hauser; Kraig V Kissinger; René M Botnar; Vidal Essebag; Mark E Josephson; Warren J Manning
Journal:  Radiology       Date:  2007-06       Impact factor: 11.105

7.  Complications of catheter ablation for atrial fibrillation: incidence and predictors.

Authors:  David D Spragg; Darshan Dalal; Aamir Cheema; Daniel Scherr; Karuna Chilukuri; Alan Cheng; Charles A Henrikson; Joseph E Marine; Ronald D Berger; Jun Dong; Hugh Calkins
Journal:  J Cardiovasc Electrophysiol       Date:  2008-05-05

8.  Early complications of pulmonary vein catheter ablation for atrial fibrillation: a multicenter prospective registry on procedural safety.

Authors:  Emanuele Bertaglia; Franco Zoppo; Claudio Tondo; Andrea Colella; Roberto Mantovan; Gaetano Senatore; Nicola Bottoni; Giovanni Carreras; Leonardo Corò; Pietro Turco; Massimo Mantica; Giuseppe Stabile
Journal:  Heart Rhythm       Date:  2007-06-21       Impact factor: 6.343

9.  Detection and quantification of left atrial structural remodeling with delayed-enhancement magnetic resonance imaging in patients with atrial fibrillation.

Authors:  Robert S Oakes; Troy J Badger; Eugene G Kholmovski; Nazem Akoum; Nathan S Burgon; Eric N Fish; Joshua J E Blauer; Swati N Rao; Edward V R DiBella; Nathan M Segerson; Marcos Daccarett; Jessiciah Windfelder; Christopher J McGann; Dennis Parker; Rob S MacLeod; Nassir F Marrouche
Journal:  Circulation       Date:  2009-03-23       Impact factor: 29.690

10.  Rate of undesirable events at beginning of academic year: retrospective cohort study.

Authors:  Guy Haller; Paul S Myles; Patrick Taffé; Thomas V Perneger; Christopher L Wu
Journal:  BMJ       Date:  2009-10-13
View more
  41 in total

Review 1.  Catheter-based ablation of atrial fibrillation: a brief overview.

Authors:  Leila Ganjehei; Mehdi Razavi; Abdi Rasekh
Journal:  Tex Heart Inst J       Date:  2011

Review 2.  Collateral Damage During Ablation of Atrial Fibrillation - Lessons Learnt in the Past Decade.

Authors:  David Spragg
Journal:  J Atr Fibrillation       Date:  2012-02-02

3.  2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation.

Authors:  Hugh Calkins; Gerhard Hindricks; Riccardo Cappato; Young-Hoon Kim; Eduardo B Saad; Luis Aguinaga; Joseph G Akar; Vinay Badhwar; Josep Brugada; John Camm; Peng-Sheng Chen; Shih-Ann Chen; Mina K Chung; Jens Cosedis Nielsen; Anne B Curtis; D Wyn Davies; John D Day; André d'Avila; N M S Natasja de Groot; Luigi Di Biase; Mattias Duytschaever; James R Edgerton; Kenneth A Ellenbogen; Patrick T Ellinor; Sabine Ernst; Guilherme Fenelon; Edward P Gerstenfeld; David E Haines; Michel Haissaguerre; Robert H Helm; Elaine Hylek; Warren M Jackman; Jose Jalife; Jonathan M Kalman; Josef Kautzner; Hans Kottkamp; Karl Heinz Kuck; Koichiro Kumagai; Richard Lee; Thorsten Lewalter; Bruce D Lindsay; Laurent Macle; Moussa Mansour; Francis E Marchlinski; Gregory F Michaud; Hiroshi Nakagawa; Andrea Natale; Stanley Nattel; Ken Okumura; Douglas Packer; Evgeny Pokushalov; Matthew R Reynolds; Prashanthan Sanders; Mauricio Scanavacca; Richard Schilling; Claudio Tondo; Hsuan-Ming Tsao; Atul Verma; David J Wilber; Teiichi Yamane
Journal:  Heart Rhythm       Date:  2017-05-12       Impact factor: 6.343

4.  Atrial mapping during pulmonary vein pacing to detect conduction gaps in a second pulmonary vein isolation procedure.

Authors:  Maria Teresa Barrio-López; Eduardo Castellanos; Mercedes Ortiz; Martín Arceluz; Carla Lázaro; Jefferson Salas; Sergio Madero; Jesús Almendral
Journal:  J Interv Card Electrophysiol       Date:  2018-05-25       Impact factor: 1.900

5.  2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society.

Authors:  Hugh Calkins; Karl Heinz Kuck; Riccardo Cappato; Josep Brugada; A John Camm; Shih-Ann Chen; Harry J G Crijns; Ralph J Damiano; D Wyn Davies; John DiMarco; James Edgerton; Kenneth Ellenbogen; Michael D Ezekowitz; David E Haines; Michel Haissaguerre; Gerhard Hindricks; Yoshito Iesaka; Warren Jackman; José Jalife; Pierre Jais; Jonathan Kalman; David Keane; Young-Hoon Kim; Paulus Kirchhof; George Klein; Hans Kottkamp; Koichiro Kumagai; Bruce D Lindsay; Moussa Mansour; Francis E Marchlinski; Patrick M McCarthy; J Lluis Mont; Fred Morady; Koonlawee Nademanee; Hiroshi Nakagawa; Andrea Natale; Stanley Nattel; Douglas L Packer; Carlo Pappone; Eric Prystowsky; Antonio Raviele; Vivek Reddy; Jeremy N Ruskin; Richard J Shemin; Hsuan-Ming Tsao; David Wilber
Journal:  Heart Rhythm       Date:  2012-03-01       Impact factor: 6.343

6.  Complications from catheter ablation of atrial fibrillation: impact of current and emerging ablation technologies.

Authors:  Nikhil C Panda; Jim W Cheung
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-10

Review 7.  2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation.

Authors:  Hugh Calkins; Gerhard Hindricks; Riccardo Cappato; Young-Hoon Kim; Eduardo B Saad; Luis Aguinaga; Joseph G Akar; Vinay Badhwar; Josep Brugada; John Camm; Peng-Sheng Chen; Shih-Ann Chen; Mina K Chung; Jens Cosedis Nielsen; Anne B Curtis; D Wyn Davies; John D Day; André d'Avila; N M S Natasja de Groot; Luigi Di Biase; Mattias Duytschaever; James R Edgerton; Kenneth A Ellenbogen; Patrick T Ellinor; Sabine Ernst; Guilherme Fenelon; Edward P Gerstenfeld; David E Haines; Michel Haissaguerre; Robert H Helm; Elaine Hylek; Warren M Jackman; Jose Jalife; Jonathan M Kalman; Josef Kautzner; Hans Kottkamp; Karl Heinz Kuck; Koichiro Kumagai; Richard Lee; Thorsten Lewalter; Bruce D Lindsay; Laurent Macle; Moussa Mansour; Francis E Marchlinski; Gregory F Michaud; Hiroshi Nakagawa; Andrea Natale; Stanley Nattel; Ken Okumura; Douglas Packer; Evgeny Pokushalov; Matthew R Reynolds; Prashanthan Sanders; Mauricio Scanavacca; Richard Schilling; Claudio Tondo; Hsuan-Ming Tsao; Atul Verma; David J Wilber; Teiichi Yamane
Journal:  Europace       Date:  2018-01-01       Impact factor: 5.214

8.  Long-term outcomes of adjunctive complex fractionated electrogram ablation to pulmonary vein isolation as treatment for non-paroxysmal atrial fibrillation.

Authors:  Alessandro De Bortoli; Ole-Jørgen Ohm; Per Ivar Hoff; Li-Zhi Sun; Peter Schuster; Eivind Solheim; Jian Chen
Journal:  J Interv Card Electrophysiol       Date:  2013-07-07       Impact factor: 1.900

9.  Postprocedural neuropathy after atrial fibrillation ablation.

Authors:  Yeruva Madhu Reddy; Dhssraj Singh; Vineela Chikkam; Sudharani Bommana; Donita Atkins; Atul Verma; Vijay Swarup; Yariv Khaykin; Srinivas Nalamachu; Mamatha Pasnoor; Dhanunjaya Lakkireddy
Journal:  J Interv Card Electrophysiol       Date:  2012-12-09       Impact factor: 1.900

Review 10.  Gender Disparities Across the Spectrum of Advanced Cardiac Therapies: Real or Imagined?

Authors:  Roberta C Bogaev
Journal:  Curr Cardiol Rep       Date:  2016-11       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.